;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Onxeo proposes EUR 35.4M rights offering

    Orphan cancer company Onxeo S.A. (Euronext:ONXEO) proposed to raise EUR 35.4 million ($44.1 million) in a rights offering underwritten by Natixis and Oddo & Cie. The company plans to issue 7.9 million shares at EUR 4.50…

    Published on 11/18/2014
  • FINANCIAL NEWS: Amicus planning $75M follow-on

    Amicus Therapeutics Inc. (NASDAQ:FOLD) said it plans to raise $75 million in a follow-on underwritten by JPMorgan; Cowen; Leerink; and Janney Montgomery Scott. The company is planning to commercialize globally its …

    Published on 11/17/2014
  • FINANCIAL NEWS: Receptos proposes $325M follow-on

    Receptos Inc. (NASDAQ:RCPT) said it plans to raise $325 million in a follow-on underwritten by Credit Suisse; Leerink; Evercore; BMO; Wedbush; and Nomura. In two prior follow-ons this year, Receptos raised $117.4 …

    Published on 11/17/2014
  • FINANCIAL NEWS: Rockwell proposes to raise $55 million

    Rockwell Medical Inc. (NASDAQ:RMTI) proposed to raise $55 million in a follow-on underwritten by BofA Merrill Lynch; Stifel, Nicolaus; Summer Street; Craig-Hallum Capital Group; Chardan Capital; and LifeSci Capital.On …

    Published on 11/17/2014
  • FINANCIAL NEWS: BeiGene raises RMB450 million

    BeiGene Co. Ltd. (Beijing, China) raised a RMB450 million ($73.6 million) in a series A round. New investors Hillhouse Capital; CITIC Capital Partners; and an undisclosed public investment fund specializing in life …

    Published on 11/14/2014
  • FINANCIAL NEWS: FibroGen surges after upsized IPO

    FibroGen Inc. (NASDAQ:FGEN) closed up $4 (22%) to $22 on its first day of trading after raising $145.8 million through the sale of 8.1 million shares at $18 in an IPO on NASDAQ. AstraZeneca plc (LSE:AZN; NYSE:AZN) …

    Published on 11/14/2014
  • FINANCIAL NEWS: Histogenics sets IPO terms

    Histogenics Corp. (Waltham, Mass.) set terms for its IPO on NASDAQ and now plans to sell 4.3 million shares at $13-$15. At the midpoint, Histogenics would raise $60 million and be valued at $151.1 million. Cowen; …

    Published on 11/14/2014
  • FINANCIAL NEWS: NeuroDerm takes haircut, raises $45M in IPO

    Neurology play NeuroDerm Ltd.(NASDAQ:NDRM) dipped $0.85 to $9.15 on Friday in its first day of trading after it raised $45 million through the sale of 4.5 million shares at $10 in its IPO on NASDAQ. The price valued …

    Published on 11/14/2014
  • FINANCIAL NEWS: Capnia prices $10.7M IPO

    Capnia Inc. (NASDAQ:CAPN) lost $2.62 (40%) to $3.88 in its first day of trading Thursday after it raised $10.7 million through the sale of 1.7 million units at $6.50 in its IPO on NASDAQ. Each unit comprises a share and…

    Published on 11/13/2014
  • FINANCIAL NEWS: Gilead raises $4B in note deal

    Gilead Sciences Inc. (NASDAQ:GILD) raised $4 billion through the sale of senior unsecured notes underwritten by Merrill Lynch; JPMorgan; Barclays; and HSBC.The notes consist of $500 million in 2.1% notes due 2020, $1.75…

    Published on 11/13/2014
  • FINANCIAL NEWS: PRA Health raises $306M in IPO

    PRA Health Sciences Inc. (NASDAQ:PRAH) gained $1.62 to $19.62 in its first day of trading on Thursday after it raised $306 million via the sale of 17 million shares at $18 in an IPO on NASDAQ. The price valued PRA at $1…

    Published on 11/13/2014
  • FINANCIAL NEWS: Blueprint raises $50 million in series C

    Blueprint Medicines (Cambridge, Mass.) raised $50 million in an untranched series C round led by new investor Partner Fund Management. Other new investors included Wellington Management; RA Capital; Tavistock Life …

    Published on 11/12/2014
  • FINANCIAL NEWS: Isis raises $425M in note deal

    Isis Pharmaceuticals Inc. (NASDAQ:ISIS) raised $425 million through the sale of senior unsecured convertible notes. The notes bear 1% interest, mature in 2021 and initially convert at $66.81.The company will use a …

    Published on 11/12/2014
  • FINANCIAL NEWS: Isis planning $425M note deal

    Isis Pharmaceuticals Inc. (NASDAQ:ISIS) proposed to raise $425 million in a private placement of senior unsecured convertible notes due 2021. The company intends to use a portion of the capital to repurchase $140 …

    Published on 11/11/2014
  • FINANCIAL NEWS: Neothetics sets IPO terms

    Neothetics Inc. (San Diego, Calif.) set terms for its IPO on NASDAQ and plans to sell 4.3 million shares at $13-$15. At $14, Neothetics would raise $60.2 million and be valued at $185.7 million. Piper Jaffray; …

    Published on 11/10/2014
  • FINANCIAL NEWS: Ziarco raises $33.1M series B

    Ziarco Pharma Ltd. (Canterbury, U.K.) raised $33.1 million in a series B round led by New Enterprise Associates and Lundbeckfond Ventures. New investor Amgen Ventures and existing investors BVF Partners and Pfizer …

    Published on 11/10/2014
  • FINANCIAL NEWS: Coherus raises $85M in IPO

    Coherus BioSciences Inc. (NASDAQ:CHRS) fell $0.89 to $12.61 in its first day of trading Thursday after raising $85 million in an IPO on NASDAQ through the sale of 6.3 million shares at $13.50. The IPO price valued …

    Published on 11/6/2014
  • FINANCIAL NEWS: Sanderling backs IRCM spinout Liphorus

    Liphorus Pharmaceuticals Inc. (Montreal, Quebec) raised $6.4 million in a series A round from Sanderling Ventures. The startup plans to develop small molecules targeting proprotein convertase subtilisin/kexin type 9 (…

    Published on 11/6/2014
  • FINANCIAL NEWS: CP Group planning investments in Karolinska

    Karolinska Development AB (SSE:KDEV) jumped SEK2.50 (18%) to SEK16.10 on Wednesday after it said Charoen Pokphand Group (Bangkok, Thailand) and its affiliates would invest in the company.First, Karolinska said it plans …

    Published on 11/5/2014
  • FINANCIAL NEWS: IPO roundup: Xenon, Molecular Partners price; Inotek files

    Xenon Pharmaceuticals Inc. (NASDAQ:XENE) and Molecular Partners AG (SIX:MOLN) each priced IPOs and began trading, while Inotek Pharmaceuticals Corp. (Lexington, Mass.) filed for a new listing.Xenon gained $1.50 (17%) to…

    Published on 11/5/2014
  • FINANCIAL NEWS: Achillion loses a lot after saying little

    Shares of HCV play Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) dropped $1.89 (16%) to $10.23 after the company released 3Q14 earnings with no updates for two highly anticipated clinical studies of its HCV compounds ACH…

    Published on 11/4/2014
  • FINANCIAL NEWS: Merieux closes EUR150M healthcare fund

    Merieux Developpement, the private equity arm of Institut Merieux, has launched its second evergreen healthcare fund with EUR150 million ($187.4 million). The fund includes a EUR75 million contribution from Sienna …

    Published on 11/4/2014
  • FINANCIAL NEWS: Molecular Partners, Neuroderm set IPO terms

    Molecular Partners AG (Schlieren, Switzerland) re-entered the IPO queue with a downsized offering on the SIX Swiss Exchange less than two weeks after postponing the listing due to market conditions, while NeuroDerm Ltd.…

    Published on 11/3/2014
  • FINANCIAL NEWS: Chimerix rises with its bank account

    Chimerix Inc. (NASDAQ:CMRX) gained $1.15 to $31.04 after completing its second big follow-on in 2014. The infectious disease company raised $105.9 million through the sale of 3.65 million shares at $29 in a deal …

    Published on 10/31/2014
  • FINANCIAL NEWS: Imago raises $26.5M series A

    Myeloid malignancy company Imago BioSciences Inc. (San Francisco, Calif.) raised $26.5 million in a series A round led by Clarus Ventures. Frazier Healthcare; Amgen Ventures; and Merck Research Labs Venture Fund also …

    Published on 10/31/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993